Nausea (most common, especially during first 1 to 2 weeks of a new dose) Diarrhea or, just as often, constipation Vomiting (less common but more likely at 9 to 12 mg) Reduced appetite, food noise quieting down (this is the goal, not a side effect) Skin sensitivity (dysesthesia): tingling, prickly feeling, or sunburn-like skin
Combining these peptides into a unified formulation allows investigation of signaling overlap, pathway convergence, and coordinated molecular responses within controlled experimental models
These health plans are designed to meet the unique needs of its beneficiaries, based on their location and status
This compound inhibits the production of tumor necrosis factor- (TNF-), interleukin-1 (IL-1), and interleukin-6 (IL-6)
10.1007/s10565-013-9262-1 Cell Biol